Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-25-020826
Filing Date
2025-02-05
Accepted
2025-02-05 16:09:32
Documents
155
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d865574d10k.htm   iXBRL 10-K 3772452
2 EX-10.8 d865574dex108.htm EX-10.8 145583
3 EX-10.20 d865574dex1020.htm EX-10.20 145341
4 EX-10.23 d865574dex1023.htm EX-10.23 58966
5 EX-19 d865574dex19.htm EX-19 89428
6 EX-21 d865574dex21.htm EX-21 7737
7 EX-23 d865574dex23.htm EX-23 2277
8 EX-31.1 d865574dex311.htm EX-31.1 10361
9 EX-31.2 d865574dex312.htm EX-31.2 10330
10 EX-32 d865574dex32.htm EX-32 4353
16 GRAPHIC g865574g0127165931745.jpg GRAPHIC 2258
17 GRAPHIC g865574g67r24.jpg GRAPHIC 109421
  Complete submission text file 0001193125-25-020826.txt   20049274

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA teva-20241231.xsd EX-101.SCH 159036
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20241231_cal.xml EX-101.CAL 91737
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20241231_def.xml EX-101.DEF 905195
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20241231_lab.xml EX-101.LAB 1017107
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20241231_pre.xml EX-101.PRE 976879
158 EXTRACTED XBRL INSTANCE DOCUMENT d865574d10k_htm.xml XML 3837045
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16174 | Film No.: 25593342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)